048530 — iNtRON Biotechnology Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩137bn
- KR₩98bn
- KR₩6bn
Annual cashflow statement for iNtRON Biotechnology, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 9,728 | 5,712 | -9,695 | -2,591 | -8,958 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 2,283 | -4,382 | 6,792 | -2,482 | 1,308 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 2,925 | 3,080 | 4,109 | 2,909 | 496 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 16,473 | 5,977 | 3,118 | -138 | -5,209 |
| Capital Expenditures | -3,494 | -2,617 | -9,552 | -1,186 | -2,470 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -37,784 | -43,605 | 61,704 | 4,256 | 3,925 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Sale of Intangible Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -41,278 | -46,221 | 52,153 | 3,070 | 1,455 |
| Financing Cash Flow Items | -0.014 | -0.01 | — | — | 30 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 39,750 | -9,191 | -40,168 | -9,818 | -2,927 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 15,243 | -49,359 | 15,175 | -6,628 | -6,696 |